º£½ÇÊÓÆµ

Oops.

Our website is temporarily unavailable in your location.

We are working hard to get it back online.

PRIVACY
Manufacturing

Vernacare sold by private equity backers in multi-million pound deal

The business employs over 250 people from its Chorley headquarters, its manufacturing plant in Bolton and its Canadian base in Toronto.

Matt Miller, chief executive, Vernacare

North west medical products manufacturer Vernacare has been sold by private equity firm Palatine for an undisclosed sum.

The Chorley-headquartered group, which has sales in excess of £60m and exports its products to 64 countries, is now backed by H.I.G. Capital.

Vernacare was established in 1964 and is a leading specialist in infection prevention.

The firm’s single-use system of toileting and cleansing is providing a sustainable alternative to traditional plastic ‘wash and re-use’ methods.

The business employs over 250 people from its Chorley headquarters, its manufacturing plant in Bolton and its Canadian base in Toronto.

Since Palatine invested in 2015, Vernacare has increased its global footprint with overseas turnover almost doubling to more than £20m.

In 2017, the company acquired and successfully integrated Synergy HCS, a manufacturer of wound care and surgical products, adding significant scale and expanding its product range.

The existing management team will be joined by James Steele who has a successful private equity background in the healthcare sector having been CEO of Attends Healthcare for twelve years.